CD36 and essential thrombocythemia: Moles-Moreau et al. (2009) investigated the diagnostic utility of PMPs, reticulated thrombocytes and CD36 expression in subjects with ET versus subjects with reactive thrombocytosis and healthy controls but discovered that these parameters cannot be employed to discriminate ET from reactive thrombocytosis.